for Immediate Release
Contact: Claire R. Wynters, Public Relations
(New York- 14 June 2007) – Criterium, Inc. announced today that it has opened a regional office in St. Petersburg, Russia. The contact information for this office is:
This office extends Criterium’s worldwide clinical trials capabilities in Russia, the former Soviet Republics and Eastern European States. The following services will be offered in conjunction with Criterium’s global full-service contract-research resources:
The Russian and Eastern European region has proven itself to be increasingly popular with worldwide pharmaceutical, biotech, and medical-device developers. They have increased the number of international multicenter trials in which this region participates by over 400% since 1998. However, when compared to the number of trials in the United States and Western Europe, there remains a large opportunity for future expansion.
The region is characterized by a strong medical system, universities and academic centers, specialized hospitals and European standards-compliant legislation, a large contingent of well-trained and highly skilled medical personnel, and a history of ICH/GCP compliance. Furthermore, this region has large potential patient population pool for many therapeutic areas that are not able to have access to modern treatments and therefore are prime candidates to enroll in clinical discovery programs.
“We are enthusiastic about this expansion and the advantages
it will bring to our clients,” noted Criterium, Inc President
and Founder John M. Hudak “this new office further emphasizes
our commitment to go to appropriate regions throughout the world to
recruit the best patient candidates as rapidly as possible. Our centralized
standard operating procedures for data management and workflow, combined
with highly trained on-the-ground field personnel for monitoring and
regulatory support, assures that every project we undertake will continue
to be conducted with the highest standards and in the most